Abstract
Glutathione was covalently attached to dextran (T-40) by the CNBr activation method. The compound obtained was a water-soluble powder containing 10 (w/w%) glutathione, which was gradually released from the conjugate in aqueous media. Mice depleted of glutathione by treatment with buthionine sulfoximine, a potent inhibitor of γ-glutamylcysteine synthetase, exhibited a significant increase in hepatic glutathione level after intravenous injection of the conjugate. In mice given a lethal dose of acetaminophen, the survival rate increased progressively with coadministration of the conjugate, whereas little improvement was found when free glutathione was given. The conjugate maintained the serum transaminase activities at lower level after acetaminophen administration. These findings suggest that the dextran conjugate of glutathione is transported into hepatic cells and is intracellulary hydrolyzed to free form, which protects mice from hepatotoxicity due to acetaminophen.
Similar content being viewed by others
REFERENCES
A. Meister and M. E. Anderson. Annu. Rev. Biochem. 52:711–760 (1983).
R. T. Jaeger, R. B. Conolly, and S. D. Murphy. Res. Commun. Chem. Pathol. Pharmacol. 6:465–471 (1973).
R. C. Schnell, H. P. Bozigian, M. H. Davies, B. A. Merrick, and K. L. Johnson. Tox. Appl. Pharmacol. 71:353–361 (1983).
R. Hahn, A. Wendel, and L. Flohé. Biochim. Biophys. Acta 539:324–337 (1978).
O. W. Griffith and A. Meister. Proc. Natl. Acad. Sci. USA 76:5606–5610 (1979).
A. Wendel and H. Jaeshke. Biochem. Pharmacol. 31:3607–3611 (1982).
L. Molteni. In G. Gregoriadis (ed.), Drug Carriers in Biology and Medicine, Academic Press, London, 1979, pp. 107–125.
R. L. Foster. Experientia 31:772–773 (1975).
J. E. Benbough, C. N. Wiblin, T. N. A. Rafter, and J. Lee. Biochem. Pharmacol. 28:833–839 (1979).
T. E. Wileman, R. L. Foster, and P. N. C. Elliott. J. Pharm. Pharmacol. 38:264–271 (1986).
R. G. Melton, C. N. Wiblin, R. L. Foster, and R. F. Sherwood. Biochem. Pharmacol. 36:105–112 (1987).
R. G. Melton, C. N. Wiblin, A. Baskerville, R. L. Foster, and R. F. Sherwood. Biochem. Pharmacol. 36:113–121 (1987).
R. Axén and S. Ernback. Eur. J. Biochem. 8:351–360 (1971).
G. L. Ellman. Arch. Biochem. Biophys. 82:70–77 (1959).
M. Dobois, K. A. Gilles, J. K. Hamilton, P. A. Rebers, and F. Smith. Anal. Chem. 28:350–356 (1956).
J. J. Marshall and M. L. Rabinowitz. J. Biol. Chem. 251:1081–1087 (1976).
J. P. Hissin and R. Hilf. Anal. Biochem. 74:214–226 (1976).
K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. J. Pharm. Dyn. 4:879–885 (1981).
O. W. Griffith and A. Meister. J. Biol. Chem. 254:7558–7560 (1979).
J. Yamamoto and M. Suzuki. Yakuzaigaku 28:73–75 (1968).
T. Matsuki and Y. Sumi. Nippon Nogeikagaku Kaishi 47:185–191 (1973).
R. L. Schnaar, T. F. Sparks, and S. Roseman. Anal. Biochem. 79:513–525 (1977).
G. Arturson and G. Wallenius. Scand. J. Clin. Invest. 16:81–86 (1964).
L. Thorén. Dev. Biol. Stand. 48:157–167 (1981).
R. W. Mowry and R. C. Millican. Am. J. Pathol. 29:523–545 (1953).
R. Sekura and A. Meister. Proc. Natl. Acad. Sci. USA 71:2969–2972 (1974).
N. Tateishi, T. Higashi, A. Naruse, N. Nakashima, H. Shiozaki, and Y. Sakamoto. J. Nutr. 107:51–60 (1977).
T. Higashi, N. Tateishi, A. Naruse, and Y. Sakamoto. J. Biochem. 82:117–124 (1977).
T. P. M. Akerboom, M. Bilzer, and H. Sies. J. Biol. Chem. 257:4248–4252 (1982).
J. R. Mitchell, D. J. Jollow, W. Z. Potter, J. R. Gillette, and B. B. Brodie. Pharmacol. Exp. Ther. 187:211–217 (1973).
B. H. Lauterburg and J. R. Mitchell. Hepatology 2:8–12 (1982).
J. R. Gillette and B. B. Brodie. J. Pharmacol. Exp. Ther. 187:195–202 (1973).
D. C. Dahlin and S. D. Nelson. J. Med. Chem. 25:885–886 (1982).
M. C. Savides and F. W. Oehme. J. Appl. Toxicol. 3:96–111 (1983).
R. F. Burk and J. M. Lane. Toxicol. Appl. Pharmacol. 50:467–478 (1979).
J. DeVries. Biochem. Pharmacol. 30:399–402 (1981).
A. Wendell and S. Feuerstein. Biochem. Pharmacol. 30:2513–2520 (1981).
A. Wendell and H. Jaeschke. Biochem. Pharmacol. 31:3601–3605 (1982).
G. M. Rosen, W. V. Singletary, E. J. Rauckman, and P. G. Killenberg. Biochem. Pharmacol. 32:2053–2059 (1983).
D. J. Reed and M. W. Fariss. Pharmacol. Rev. 36(Suppl.):25s–33s (1984).
M. Davis, C. J. Simmons, N. G. Harrison, and R. Williams. Q. J. Med. 45:181–191 (1976).
W. Bolanowska and T. Gessner. J. Pharmacol. Exp. Ther. 206:233–237 (1978).
A. Klutch, M. S. Levin, R. L. Chang, F. Vane, and A. H. Conney. Clin. Pharmacol. Ther. 24:287–293 (1978).
L. F. Prescott and J. A. J. H. Critchley. Annu. Rev. Pharmacol. Toxicol. 23:87–101 (1983).
B. H. Lauterburg, G. B. Corcoran, and J. R. Mitchell. J. Clin. Invest. 71:980–991 (1983).
J. O. Miners, R. Drew, and D. J. Birkett. Biochem. Pharmacol. 33:2995–3000 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaneo, Y., Fujihara, Y., Tanaka, T. et al. Intrahepatic Delivery of Glutathione by Conjugation to Dextran. Pharm Res 6, 1025–1031 (1989). https://doi.org/10.1023/A:1015922303051
Issue Date:
DOI: https://doi.org/10.1023/A:1015922303051